Emergent Biosolutions, Inc. (
Q4 2011 Earnings Call
March 8, 2012 5:00 PM ET
Bob Burrows – VP, IR
Fuad El-Hibri – Chairman and CEO
Don Elsey – SVP, Finance and Administration and CFO
Good day, ladies and gentlemen and welcome to the Fourth Quarter 2011 Emergent Biosolutions Earnings Conference Call. My name is Jeremy and I will be your operator for today. At this time, all participants are in listen-only mode. Later we will conduct a question-and-answer session. (Operator Instructions).
I would now like to turn the conference over to your host for today, Mr. Bob Burrows, Vice President of Investor Relations.
Thank you, Jeremy. Good afternoon, ladies and gentlemen, thank you for joining us today as we discuss Emergent BioSolutions fourth quarter and full-year 2011 financial results. As is customary, our call today is open to all participants. In addition, the call is being recorded and is copyrighted by Emergent BioSolutions.
Joining me on the call this afternoon with prepared comments will be Fuad El-Hibri, our Chairman and Chief Executive Officer and Don Elsey, our Chief Financial Officer. Additional members of our senior management team will be present on the call for purposes of the Q&A session.
Before we begin, I am compelled to remind everyone that during the call management may make projections and other forward-looking statements regarding future events and the company’s prospects or future performance. These forward-looking statements reflect Emergent’s current perspective on existing trends and information. Any such forward-looking statements are not guarantees of future performance and involve potential risks and uncertainties. Actual results may differ materially from those projected in any forward-looking statements. You’re encouraged to review Emergent’s filings with the SEC on forms 10-K, 10-Q and 8-K for more information on the risks and uncertainties that could cause actual results to differ.